settles: search

AstraZeneca settles U.S. Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals

Add our medical news to StumbleUpon - AstraZeneca settles U.S. Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals Add our medical news to Facebook - AstraZeneca settles U.S. Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals

Itron settles lawsuit claiming patent infringement: Spokane firm makes wireless utility meters

TMCNet: Itron settles lawsuit claiming patent infringement: Spokane firm makes wireless utility meters

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Ivax Pharmaceuticals - Quick Facts

(RTTNews) - Tuesday, AstraZeneca plc (AZN, AZN.L) said it signed a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals Inc., a subsidiary of Teva Pharmaceuticals USA. The agreement settles the patent infringement litigation filed by AstraZeneca following Teva's submission to the United States Food & Drug Administration of an Abbreviated New Drug Application for a generic version of Pulmicort Respules.

Samsung settles with Interdigital on patent-infringement case

Samsung has settled a pair of patent-infringement lawsuits with Interdigital. Just in the nick of time, as well. The settlement was reached on Monday, with Tuesday being the day that the U.S. International Trade Commission was set to rule on whether it would ban imports of Samsung's cell phones over the case.

Crossroads Settles Patent Suits

Optimizing File Storage Infrastructure with Adaptive Resource Networking - by Acopia Networks Inc. 12/12/2003

InterDigital settles patent licensing disputes with Samsung

InterDigital has announced that InterDigital Communications and its patent licensing subsidiaries have entered into a binding term sheet with Samsung Electronics and its affiliates, including Samsung Electronics America, which resolves the outstanding arbitration issues involving Samsung's sale of 2G products, as well as the 3G patent licensing disputes for Samsung's sales of products through 2012.

AstraZeneca settles US Pulmicort Respules patent litigation with Ivax

AstraZeneca has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc, a wholly-owned subsidiary of Teva Pharmaceuticals USA.

InterDigital settles patent licensing disputes with Samsung

InterDigital has announced that InterDigital Communications and its patent licensing subsidiaries have entered into a binding term sheet with Samsung Electronics and its affiliates, including Samsung Electronics America, which resolves the outstanding arbitration issues involving Samsung's sale of 2G products, as well as the 3G patent licensing disputes for Samsung's sales of products through 2012.

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

LONDON, Nov. 25, 2008-AstraZeneca today announced it has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA.

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

PRNewswire-FirstCall/ -- AstraZeneca today announced it has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA.

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

WILMINGTON, Del., Nov. 25 /PRNewswire-FirstCall/ -- AstraZeneca today announced it has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA.

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

Court Grants AstraZeneca (AZN) Request for Temporary Restrain on Further Sales of Teva's (TEVA) Generic Version of Pulmicort

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

PRNewswire-FirstCall/ -- AstraZeneca today announced it has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA.

Samsung settles 3G patent dispute with InterDigital

Email the Editor Email the Editor Email a Friend Email a Friend about this article Print this Page Print friendly page

InterDigital Settles Mobile Phone Patent Dispute with Samsung

InterDigital says that it has settled an ongoing patent dispute with Samsung - and entered into a binding term sheet with the company covering Samsung’s sale of 2G products, as well as the 3G patent licensing disputes for Samsung’s sales of products through 2012.

Samsung settles 3G patent dispute with InterDigital

Samsung Electronics entered into a patent licensing agreement with InterDigital on Monday, just a day ahead of a U.S. decision on whether or not to bar Samsung 3G handsets from entering the country.

Samsung Settles 3G Patent Dispute with InterDigital

Samsung Electronics entered into a patent licensing agreement with InterDigital on Monday, just a day ahead of a U.S. decision on whether or not to bar Samsung 3G handsets from entering the country.

ING settles dispute with Dutch consumer organizations on life cost charges

ING has announced that Nationale-Nederlanden and its other Dutch insurance subsidiaries have reached agreements with the Stichting Verliespolis and Stichting WPC and their related consumer organizations to resolve a dispute regarding the cost charges related to individual universal life insurance products sold to customers in the Netherlands.

InterDigital Settles Samsung Patent Licensing Disputes; Shares Up - Update

(RTTNews) - Monday, wireless technologies developer InterDigital, Inc. (IDCC: News ), said that InterDigital Communications and its patent licensing subsidiaries have entered into a binding term sheet with Samsung Electronics and its affiliates, including Samsung Electronics America. The term sheet finally resolves the outstanding arbitration issues involving Samsung's sale of 2G products, as well as the 3G patent licensing disputes for Samsung's sales of products through 2012. Following the news, InterDigital shares moved up over 14.5% in after-hours trade on the Nasdaq.

Beacon Settles Arete's Flywheel Patent Lawsuit

Law360, New York (November 24, 2008) -- Energy technology company Beacon Power Corp. has settled a lawsuit filed by Arete Power Inc. over an Arete patent related to flywheel energy storage technology.

Google Settles Book Search Suit

Faced with a fundamental disagreement over copyright law, with major implications for the future of the web, the parties in two three-year-old lawsuits over Google's controversial library scan plan opted for an “audacious” (according to one plaintiff), if expected, settlement strategy: they agreed to disagree on the core copyright argument of the case and instead focused on business.

Google Settles With Book Publishers

Google recently reached an agreement with the Authors Guild and the Association of American Publishers under which the firm will pay USD125m to resolve outstanding legal actions against it in relation to its Google Book search service, which offers full-text searching facilities to users.

Sanofi settles US patent dispute with Teva and Barr

Sanofi-Aventis says it has agreed to settle patent infringement suits in the USA with Barr Laboratories and Teva Pharmaceutical Industries over generic versions of the allergy drugs Allegra and Nasacort.

Barr settles Nasacort AQ, Allegra D-12 & Allegra patent challenges

Barr Pharmaceuticals, Inc announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg tablets. As part of the settlements, the parties have agreed to dismiss the underlying US litigation related to the three patent challenge cases.

Sanofi settles some Allegra, Nasacort patent suits

Wednesday said it agreed to settle some patent infrigement suits in the U.S. with drug makers Barr Pharmaceuticals Inc

Search took 0.02 seconds.